ADAR1 Capital Management, LLC
10% owner, NextCure, Inc.; 10% owner, InMed Pharmaceuticals Inc.; 10% owner, Tenax Therapeutics, Inc.; 10% owner, Rallybio Corp
Bought, 12 months
$5.8M
Sold, 12 months
$0.0M
Companies
4
Latest trade
Oct 27, 2026
Companies
NextCure, Inc.10% owner +$1.7M InMed Pharmaceuticals Inc.10% owner +$0.1M Tenax Therapeutics, Inc.10% owner +$3.1M Rallybio Corp10% owner +$0.9MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.



